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Abstract Cyclic ADP-ribose (cADPR) is a natural metabolite
of L-NAD+ with a potent Ca2+-mobilizing activity in different
cell types, including T-lymphocytes. We investigated (i) whether
stimulation of T-lymphocytes with different agonists affects the
intracellular concentration of cADPR, and (ii) whether the
lymphocyte antigen CD38, through its ectocellular ADP-ribosyl
cyclase and cADPR-hydrolase enzymatic activities, can account
for the regulation of the intracellular levels of cADPR and the
Ca2+-mobilizing effects of this nucleotide in Jurkat and
HPB.ALL T-lymphocytes. The anti-CD3 antibody OKT3, the
sphingolipid sphingosine and lysophosphatidic acid induced an
increase in intracellular cADPR with concomitant increases in
the intracellular Ca2+ concentration ([Ca2+]i). In contrast,
activation of an ectocellular ADP-ribosyl cyclase by preincuba-
tion of cells with L-NAD+ led to a dose-dependent increase in
cADPR, but no changes in [Ca2+]i were observed. However,
extensive washing of the cells following preincubation with
NAD+ demonstrated that the increases in cADPR were not
intracellular but due to cell surface-associated nucleotide.
Accordingly, measurements of ADP-ribosyl cyclase activity in
intact T-cells showed ectocellular synthesis of cADPR, but no
evidence was obtained for a shift of this activity into the cells
which could account for intracellular accumulation of cADPR.
Taken together, the results indicate no direct involvement of the
ADP-ribosyl cyclase activity of CD38 on the regulation of the
cADPR-mediated intracellular Ca2+-signalling in T-lympho-
cytes.
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1. Introduction
Cyclic ADP-ribose (cADPR) is a natural metabolite of L-
NAD with a potent Ca2-mobilizing activity in di¡erent cell
types, including hepatocytes, pancreatic and adrenal chromaf-
¢n cells, macrophages, PC12 cells and T-lymphocytes [1^4].
At present, it is still debatable whether cADPR functions as a
second messenger in response to stimulation of membrane
receptors and little is known about the mechanisms by which
the intracellular concentration of this nucleotide is regulated.
Identi¢cation and characterization of the enzymatic activities
responsible for the synthesis and hydrolysis of cADPR are
important for elucidating this question.
CD38 is a type II transmembrane glycoprotein predomi-
nantly expressed on the activated phenotypes of lymphoid
and monocytic cells, but is also reported to be present in
many other eukaryotic cell types [5^7]. Considerable interest
on the CD38 glycoprotein has emerged from the fact that it is
also a bifunctional ectoenzyme, catalyzing both the synthesis
and the hydrolysis of cADPR [5^7]. The two enzyme activities
are located at the ectocellular, C-terminal domain of CD38
and are de¢nided as ADP-ribosyl cyclase, which catalyzes the
synthesis of cADPR and nicotinamide from L-NAD, and
cADPR hydrolase, which degrades cADPR to ADPR [8,9].
The possibility that the ADP-ribosyl cyclase activity of CD38
might be responsible for the synthesis of endogenous cADPR
in various cell types has been considered by di¡erent groups.
However, the apparent contradiction between ectocellular
CD38-catalyzed synthesis and intracellular Ca2-mobilizing
activity of cADPR is so far unresolved and conclusive evi-
dence for a link between CD38 and intracellular cADPR is
still lacking. In this study, we also addressed the question
whether CD38 may be involved in the regulation of endoge-
nous cADPR in human T-lymphocyte cell lines, and obtained
data which clearly indicate no direct role for the ADP-ribosyl
cyclase/cADPR hydrolase activities of CD38 in regulating in-
tracellular cADPR and, consequently, cADPR-mediated
Ca2-signalling in Jurkat and HPB.ALL T-lymphocytes.
2. Materials and methods
2.1. Materials
cADPR was either purchased from Amersham-Buchler (Braun-
schweig, Germany) or was prepared enzymatically from L-nicotin-
amide adenine dinucleotide (L-NAD), as previously reported [10].
ADP-ribose, L-NAD, K-NAD and NGD were obtained from
Sigma (Deisenhofen, Germany). Fura-2/AM was purchased from
Calbiochem (Bad Soden, Germany). The anti-CD3 monoclonal anti-
body OKT3 was puri¢ed from hybridoma supernatants on Protein G
Sepharose (Pharmacia Biotech, Freiburg, Germany). Perchloric acid,
methanol (LiChrosolv) and tri£uoroacetic acid were purchased from
Merck (Darmstadt, Germany) and tetrabutylammonium dihydrogen
phosphate was obtained from Fluka (Neu-Ulm, Germany). All
other chemicals were of the highest purity available. MilliQ water
(Millipore Waters, Eschborn, Germany) was used throughout all ex-
periments.
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2.2. Cell culture
The human T-lymphocyte cell lines Jurkat and HPB.ALL were
cultured as described in earlier publications [11,12].
2.3. Measurement of [Ca2+]i
[Ca2]i was determined by spectro£uorometry, as previously de-
scribed [11,12]. In brief, cells (1U106 cells) were loaded with Fura-
2/AM (1 WM) in a medium containing (in mM): 140 NaCl, 5 KCl,
1 MgSO4, 1 CaCl2, 1 NaH2PO4, 5.5 glucose and 20 HEPES (pH 7.4).
Measurements of £uorescence were subsequently performed in ali-
quots containing 2U105 cells using a Hitachi F-2000 £uorimeter
with wavelength settings alternating between 340 þ 2.5 nm and
380 þ 2.5 nm (excitation ratio mode) and 510 þ 5 nm (emission) at
room temperature.
2.4. Assay of ADP ribosyl cyclase activity
ADP ribosyl cyclase activity was measured £uorimetrically either in
intact cells or in subcellular fractions obtained after centrifugation of
cell homogenates at 100 000Ug (the resulting membrane and cytosolic
fractions were designated P100 and S100, respectively). The assays
were performed essentially as described in [13,14]. The cells or protein
fractions were incubated in extracellular bu¡er (as indicated above for
[Ca2]i measurements) at 37‡C under continuous stirring. Enzymatic
production of cGDPR from NGD (0.1 mM) was monitored contin-
uously at 410 nm (emission wavelength) with an excitation wavelength
set at 300 nm, using a Hitachi F-2000 £uorimeter.
2.5. HPLC analysis of cADPR
Endogenous cADPR was extracted from unstimulated and stimu-
lated cells using the perchloric acid procedure described in [15]. Quan-
ti¢cation of cADPR in cell extracts was performed with a recently
developed two-step HPLC method, which consists of a strong anion-
exchange chromatography followed by a second, ion-pair reversed
phase HPLC [15]. The ¢rst HPLC step was carried out on a PRPX
100 matrix (10 Wm, Hamilton, Switzerland) packed into a 250U4.6
mm I.D. PEEK column (CS Chromatographie Services, Germany). A
gradient from 1 mM Tris, pH 8.0, to 150 mM TFA was used at a £ow
rate of 1.5 ml/min. The gradient was (in % of eluent B): 0 min, 5%;
5 min, 5%; 12 min, 21%; 13 min, 21%; 25 min, 50%; 26 min, 5%;
29.5 min, 5%. Material co-eluting with standard cADPR was col-
lected, lyophilized and redissolved in 200 Wl of reversed-phase ion-
pair HPLC bu¡er (20 mM KH2PO4, 5 mM tetrabutylammonium
hydrogen phosphate, pH 6.0). The reversed-phase HPLC column
used was a Hypersil BDS C18 column (5 Wm; 250U4.6 mm I.D.;
Hypersil, Cheshire, UK). A gradient from reversed-phase ion-pair
bu¡er (see above) to methanol was used at a £ow rate of 1.0 ml/
min. The gradient was (in % of methanol): 0 min, 5%; 3 min, 15%;
8 min, 50%; 16 min, 50%; 18 min, 5%; 21 min, 5%.
The UV-absorbance detector (model 432, Kontron Instruments)
was autozeroed at the start of each chromatogram and absorbance
was measured at 270 nm. Data was processed by the MT2 data ac-
quisition system from Kontron Instruments. Identi¢cation of the
cADPR peak in cell samples was con¢rmed by co-chromatography
with the standard compound.
2.6. Flow cytometry
Cells (1U105 cells) were resuspended in PBS bu¡er containing 5%
FCS and 0.05% NaN3 and incubated for 10 min at 4‡C with human Q-
immunoglobulin in order to block Fc-receptors. Then the cells were
incubated with an anti-CD38 monoclonal antibody (5 Wg/ml) for 1 h,
at 4‡C. After two washes with PBS, cells were further incubated with
FITC-conjugated goat anti-mouse IgG (45 min, 4‡C). The analysis of
£uorescence was performed on a FACSorter (Becton Dickinson, Hei-
delberg, Germany) with an excitation wavelength set at 430 nm.
2.7. Preparation of subcellular fractions and Western blot
Jurkat cells (109 cells) were disrupted in 5 ml of bu¡er (20 mM
HEPES, pH 7.5, 110 mM NaCl, containing the protease inhibitors
antipain 5 Wg/ml, leupeptin 5 Wg/ml, pepstatin 6.9 pg/ml and Pefablock
SC 13.9 Wg/ml) using a Potter-Elvehjem homogenizer at 4‡C. The
homogenate was centrifuged at 500Ug for 10 min, the supernatant
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Fig. 1. Increases in endogenous cADPR and [Ca2]i in Jurkat T-
lymphocytes, in response to stimulation with di¡erent agonists. Ju-
rkat T-lymphocytes (106^108 cells) were collected by centrifugation
and incubated in an extracellular bu¡er, for 15 min at 37‡C. The
cells were then stimulated with (A) the anti-CD3 antibody OKT3
(10 Wg/ml), (B) sphingosine, SPH (10 WM), (C) LPA (40 WM) or (D)
L-NAD (1 mM). As indicated by the bars, endogenous cADPR was
extracted before (open bars) and after stimulation with each com-
pound (¢lled bars) and subsequently measured by a 2-step HPLC
method, as described [15]. [Ca2]i was continuously monitored in a
suspension of Fura-2 loaded cells, before and after stimulation with
each of the compounds indicated. Data are presented as
mean þ S.D. (n = 4^14). The basal cADPR values shown in B and C
are from di¡erent series of experiments than in A and D. The
[Ca2]i tracings are representative of, at least, 10 independent meas-
urements.
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collected and further centrifuged at 10 000Ug (20 min, 4‡C). The
pellet (P10 fraction) was discarded and the supernatant centrifuged
at 100 000Ug for 2 h at 4‡C. The pellet thus obtained (P100 fraction)
was harvested and used for Western blot of CD38 or for ADP-ribosyl
cyclase assay (see Section 2.4).
Protein (100 Wg) was boiled at 95‡C for 5 min and subjected to
SDS-PAGE in a 12.5% gel (3% stacking gel) under reducing condi-
tions. Proteins were subsequently transferred onto nitrocellulose
sheets by tank blotting (1.5 h, 660 mA constant, 4‡C). The nitrocel-
lulose sheets were immunostained with an anti-CD38 antibody
(4 Wg/ml) and, after thorough washing by a complex procedure, the
blots were developed using the ECL-kit (Amersham), according to the
manufacturer’s instructions.
3. Results and discussion
We have previously shown that cADPR induced Ca2-mo-
bilization from intracellular stores in Jurkat and HPB.ALL T-
lymphocytes [1]. More recently we have analyzed the e¡ects of
stimulation of T-lymphocytes with di¡erent Ca2-mobilizing
agonists, e.g. anti-CD3 monoclonal antibodies, sphingosine
and lysophosphatidic acid (LPA), on the intracellular levels
of cADPR. Upon stimulation of Jurkat T-cells with these
agonists, parallel increases in the endogenous levels of
cADPR and in [Ca2]i were observed (Fig. 1A^C). In con-
trast, incubation of Jurkat T-cells with high concentrations of
NAD resulted in a highly increased cell-associated cADPR
concentration, but in an almost non-detectable stimulation
of intracellular Ca2-signals (Fig. 1D). Similar e¡ects of
NAD were obtained when using HPB.ALL T-cells (data not
shown).
These observations prompted us to investigate which en-
zyme(s) are involved in the regulation of endogenous cADPR
in human T-cells and, in particular, whether the lymphocyte
antigen CD38 might play a role in this process.
FACS analysis and Western blotting of cell surface expres-
sion of CD38 in Jurkat and HPB.ALL T-lymphocytes dem-
onstrated the presence of the antigen in both cell lines,
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Table 1
NAD does not induce internalization of the ADP-ribosyl cyclase/CD38 in Jurkat T-lymphocytes
Surface expression of CD38 (FI, mean þ S.D.)a cGDPR £uorescenceb Cyclase activity (%)c
% pelleted % extracellular
Control 28.0 þ 5.0 ^ ^ 100.0
NAD (1 mM) 30.5 þ 3.5 ^ ^ 64.2
NGD (0.1 mM) ^ 3.0 97.0 ^
Nicotinamide (1 mM) ^ ^ ^ 60.2
aSurface expression of CD38 was measured by FACS analysis in Jurkat T-cells, before and after treatment with NAD (1 mM) for 1^2 h. FI,
£uorescence intensity in arbitrary units.
bUsing the NGD assay, the £uorescence due to cyclase-synthesized cGDPR was measured after centrifugation of the reaction mixture both in the
cell pellets (taken as an indication of intracellularly localized compound) and in the extracellular medium. Results are given as % of total
£uorescence (n = 6).
cThe e¡ects of preincubation of Jurkat cells with NAD (1 mM, 30 min) or nicotinamide (1 mM, 30 min) on the ADP-ribosyl cyclase activity were
measured using the NGD assay. Results are expressed as % of control values and are representative of 6 experiments carried out.
Fig. 2. Expression of CD38 in Jurkat T-lymphocytes. A: FACS
analysis of cell surface expression of CD38 in Jurkat cells was per-
formed as described in Section 2, using a mouse anti-CD38 mono-
clonal antibody (5 Wg/ml). B: Western blot of CD38 in P100 mem-
brane fractions from Jurkat cells was performed as described in
Section 2. The arrow shows a band of approximately 45 kDa immu-
nostained with the anti-CD38 antibody and corresponding to mem-
brane-bound CD38. The position and molecular weight of marker
proteins are also shown.
C
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although relatively higher levels of expression of this molecule
were observed in HPB.ALL cells, as compared to Jurkat cells
(see Fig. 2 for data obtained on CD38 expression in Jurkat
cells).
The high amount of cADPR formed after incubation of the
cells with NAD and the obvious lack of stimulation of Ca2-
signalling suggested that the cADPR produced did not reach
its intracellular target site, the ryanodine receptor. In order to
check this hypothesis, cells were subjected to thorough and
extensive washing steps, following incubations with NAD and
before extraction of cADPR. The results shown in Fig. 3A
indicate that, in fact, upon extensive washing of the cells the
levels of cADPR measured were not signi¢cantly di¡erent
from endogenous control values. These results, therefore,
demonstrate that the increased amounts of cADPR synthe-
sized by the cyclase in the presence of high extracellular con-
centrations of NAD remain outside the cells, essentially mem-
brane-associated, instead of being either produced
intracellularly, by potentially internalized CD38 molecules or
transported, by an unknown mechanism, into the cells. It
should be noted that such an extensive washing of the cells
before extraction of cADPR was not necessary when the cells
were stimulated with the other agonists (Fig. 1A^C), since the
extracellular bu¡er did not contain any NAD. Moreover, a
potential overestimation of the cADPR values measured by
HPLC due to co-chromatography with other compounds can
also be excluded, based on our previous demonstration that
the cADPR peak is completely converted to ADPR upon heat
inactivation [15].
As shown in Fig. 3B, a dose-dependent increase in cell-
associated cADPR was detected when cells were pre-incu-
bated with L-NAD. In the presence of 1 mM L-NAD,
approximately 3- and 10-fold increases in cell-associated
cADPR, as compared to control levels, were measured in
Jurkat and HPB.ALL cells, respectively. In contrast, K-
NAD, which is not a substrate for the ADP-ribosyl cyclase
CD38, induced no signi¢cant changes in cell-associated
cADPR levels, in comparison to control values (Fig. 3C).
The speci¢city for L-NAD provides evidence for the involve-
ment of the ADP-ribosyl cyclase CD38 on the NAD-induced
increases of cell-associated cADPR.
In spite of the numerous investigations which have been
conducted on the CD38-cADPR system [5^7,16^20], a still
unresolved question is the relationship between the CD38-cat-
alyzed production of cADPR which takes place in the extra-
cellular space and the intracellular calcium-mobilizing activity
of the nucleotide. As has been suggested from experiments
with neuronal and lymphoid cells [16^18], a possible mecha-
nism underlying an NAD-induced increase in intracellular
cADPR would be an NAD-dependent internalization of
CD38 with a concomitant shifting of cADPR metabolism to
the intracellular environment. Previous studies have, in fact,
shown that internalization of CD38 into cytoplasmic vesicles
can occur in Namalwa B lymphoid cells [16,18]. These obser-
vations, however, raise further questions on the accessibility
of the luminally-localized catalytic site of the CD38 molecule
to cytosolic NAD and, on the other hand, of intravesicular-
generated cADPR to its cytosolic target.
However, Zocchi and collaborators [16,18] reported exten-
sive decreases in ectocellular ADP-ribosyl cyclase activity in
intact Namalwa B-lymphoma cells, following incubation with
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Table 2
E¡ects of L-NAD and anti-CD38 on [Ca2]i in Jurkat T-lympho-
cytes
Compound added [Ca2]i (nM)
^ 116 þ 16.8
OKT3 (10 Wg/ml) 533 þ 68*
IB4 (10 Wg/ml) 112 þ 18
L-NAD (1 mM) 130 þ 30
L-NAD (1 mM)+OKT3 (10 Wg/ml) 470 þ 44*
[Ca2]i was measured £uorimetrically in suspensions of Fura-2 loaded
Jurkat T-cells, before and after addition of the compounds indicated.
Increased levels of [Ca2]i refer to plateau values. Results are the
mean þ S.D. of 4^10 independent measurements. Asterisks denote
statistically signi¢cant di¡erences from basal values, according to
the Student’s t-test (Ps 0.99).
Fig. 3. E¡ect of exogenous NAD on the production of cADPR by
an ADP-ribosyl cyclase in T-lymphocytes. A: Jurkat cells (1U108
cells/5 ml of extracellular bu¡er) were incubated for 15 min, at
37‡C, either in the absence (control) or in the presence of L-NAD
(1 mM). NAD-treated cells were subsequently centrifuged and
washed 3 times with 10 ml of extracellular bu¡er. cADPR was then
extracted and quanti¢ed by HPLC. B: Cells (107^108 cells/sample)
were preincubated with L-NAD, in the concentrations indicated,
for 15 min, at 37‡C. cADPR was subsequently extracted from
Jurkat (b) and HPB.ALL cells (F) and analyzed by HPLC, as de-
scribed in [15]. C: Jurkat T-cells were incubated in the absence
(control) or in the presence of either L-NAD or K-NAD (1 mM),
for 15 min at 37‡C, before extraction and analysis of cADPR. Re-
sults are the mean þ S.D. of 3^26 independent experiments.
*Ps 0.99, **Ps 0.98.
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NAD. According to those authors, such observations were
taken as an indication of NAD-induced internalization of
CD38. In the present work, we also analyzed the e¡ects of
preincubation of Jurkat and HPB.ALL T-cells with NAD on
the ectocellular cyclase activity. The following evidence
against NAD-induced internalization of CD38 was obtained
in our cell systems (Table 1): (i) FACS analysis showed no
decrease in the cell surface expression of CD38 in Jurkat
and HPB.ALL lymphocytes, after 1 h of exposure to NAD
(1 mM); (ii) using the NGD-assay of ADP-ribosyl cyclase
activity employing intact cells we observed that, after centri-
fugation of the cells, almost all the £uorescence due to enzy-
matically-synthesized cGDPR was found in the extracellular
medium and not in the cell pellet; and (iii) preincubation with
nicotinamide (which, together with cADPR, is also a product
of the cyclase-catalyzed conversion of NAD) as well as with
NAD inhibited the ADP-ribosyl cyclase activity, suggesting
that rather a product-inhibition of the enzyme instead of in-
ternalization may be the reason for the observed decreases in
ectocellular cyclase induced by NAD.
Another hypothesis recently proposed by Prasad and col-
laborators is based on a structural model for CD38 consisting
of a dimer possessing a central cavity formed by head-to-head
association of two monomers. According to this model, the
catalytic domain of CD38 is located in the central cavity of
the pore-forming dimeric structure, which could then form a
channel to allow cADPR generated from extracellular NAD
to enter the cell [19]. While such a model was proposed on the
basis of elucidation of the tridimensional structure of the
soluble ADP-ribosyl cylase from Aplysia californica, direct
evidence for the existence of a similar structure for the
CD38 molecule in mammalian cells has, so far, not been ob-
tained.
None of the models mentioned above is, however, compat-
ible with data obtained in this work on the e¡ects of NAD on
[Ca2]i in the T-cell lines studied. In fact, according to such
models, if a direct coupling between NAD-induced ectocellu-
lar production of cADPR and intracellular activity of the
cyclic nucleotide would exist, it would be expected that
NAD, per se, would also induce an increase in [Ca2]i. In
contrast, as shown in Fig. 1, we observed no signi¢cant
changes in [Ca2]i in T-cells, following incubation with
L-NAD. Also ligation of CD38 with the agonistic mono-
clonal antibody IB4 had no e¡ect on [Ca2]i in our Jurkat
T-cell clone (Table 2). Moreover, preincubation of Jurkat
cells with L-NAD also had no in£uence on subsequent
OKT3-stimulated increases in endogenous cADPR (Table 2).
Our conclusion that CD38/ADP-ribosyl cyclase is not in-
volved in synthesis of intracellular cADPR was further con-
¢rmed by direct £uorimetric measurements of the CD38/
ADP-ribosyl cyclase activity in intact Jurkat and HPB.ALL
cells, as well as in subcellular fractions.
The results represented in Fig. 4A were performed with
intact cells and show that both cell lines contained an ectoen-
zymatic cyclase activity, although HPB.ALL cells present rel-
atively higher activity levels than Jurkat lymphocytes. The
relative magnitudes of the ectocellular cyclase activities
(130 þ 20 pmol cGDPR/min/106 cells for HPB.ALL and
58 þ 14 pmol cGDPR/min/106 cells for Jurkat lymphocytes)
were in contrast with the relative basal levels of intracellular
cADPR measured in the absence of extracellular NAD in
these cell lines (22.4 þ 6.2 and 101.7 þ 21.6 pmol of cADPR/
108 cells, in HPB.ALL and in Jurkat cells, respectively).
Although the e¡ective endogenous concentration of cADPR
is the result of a balance between cyclase and hydrolase activ-
ities, the lack of correlation between the two parameters men-
tioned above also suggests no direct coupling of the CD38/
ADP-ribosyl cyclase to the synthesis of intracellular cADPR.
Further characterization of the membrane-bound cyclase
activity, most likely CD38, was also performed in P100 frac-
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Fig. 4. Fluorimetric assays of ADP-ribosyl cyclase activity in Jurkat and HPB.ALL T cells. Cells (3U105 cells/600 Wl of extracellular bu¡er)
were incubated in a cuvette at 37‡C, under continuous stirring. After 3 min, NGD (100 WM) was added and the subsequent increases in
cGDPR £uorescence were continuously monitored for an additional 10 min. Two representative tracings from each T-cell line are shown
(Jurkat cells, continuous line; HPB.ALL cells, broken line). B: Cyclase activity was measured in the P100 fraction from Jurkat cells (1 mg pro-
tein/ml of extracellular bu¡er), as described in A. The enzymatic reaction showed a typical Michaelis-Menten kinetic and from the Lineweaver-
Burk plot of the experimental data, the kinetic constants Km and Vmax were determined. The results represent the mean þ S.D. of 7^11 inde-
pendent measurements, performed with 4 di¡erent preparations of Jurkat cell membranes. C: P100 fractions were prepared from unstimulated
and OKT3-stimulated (10 Wg/ml, 10 min) Jurkat lymphocytes and cyclase activity was subsequently measured, under the same conditions, in
both membrane fractions.
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tions prepared from Jurkat cells. Fig. 4B shows a typical
£uorimetric tracing of cyclase activity measurement in the
P100 membrane fraction and the correspondent data of ki-
netic analysis. The cyclase-catalyzed reaction showed a typical
Michaelis-Menten kinetics and from the Lineweaver-Burk
plot of the experimental data the kinetic constants Km = 13
WM and Vmax = 79 pmol cGDPR/min/mg protein were deter-
mined.
Along these lines, another observation in support of our
view was that no signi¢cant changes in the membrane-bound
cyclase activity were observed in P100 fractions prepared from
Jurkat cells which had been pre-stimulated with the anti-CD3
monoclonal antibody OKT3 (Fig. 4C). If CD38 would be
involved in TCR/CD3 complex-mediated cADPR formation,
the opposite result might be expected.
However, CD38 may have a role in the long term regula-
tion of basal levels of cADPR. In fact, Zocchi et al. [21] have
shown that transfection of a cDNA for CD38, followed by
expression of CD38 in CD383 HeLa and 3T3 cells resulted in
increased intracellular cADPR, accompanied by a modest in-
crease in basal [Ca2]i. In addition, a reduction in cell dou-
bling time in close correlation with the increased expression of
ectocellular cyclase/CD38 activity was observed [21]. Takaha-
shi and collaborators [22] also showed that di¡erentiation of
HL-60 cellls with retinoic acid was accompanied by an eleva-
tion of CD38 expression and a concomitant increase in basal
intracellular cADPR, but the mechanism involved in these
e¡ects is not known.
In conclusion, the results obtained in this work demonstrate
that the ADP-ribosyl cyclase activity of the CD38 glycopro-
tein is not responsible for the agonist-induced increases in
cADPR in human T-cells and, consequently, does not play
a major role in the regulation of cADPR-mediated Ca2-sig-
nalling in T-lymphocytes. However, a modulatory long term
e¡ect of CD38 on the basal level of cADPR in eukaryotic cells
cannot be ruled out completely, at present.
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